NSE - Delayed Quote INR

Arvee Laboratories (India) Ltd. (ARVEE.NS)

Compare
154.79
-1.26
(-0.81%)
At close: 3:29:05 PM GMT+5:30
Loading Chart for ARVEE.NS
DELL
  • Previous Close 156.05
  • Open 158.07
  • Bid --
  • Ask --
  • Day's Range 154.43 - 158.90
  • 52 Week Range 117.05 - 315.00
  • Volume 332
  • Avg. Volume 6,508
  • Market Cap (intraday) 1.706B
  • Beta (5Y Monthly) 0.53
  • PE Ratio (TTM) 74.42
  • EPS (TTM) 2.08
  • Earnings Date Feb 11, 2025 - Feb 15, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India and internationally. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinitrobenzoic acid and 3,5-diamino benzoic acid. It also provides drug intermediates comprising 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4–amino pyridine, and 2–chloro–5–nitrobenzoic acid. In addition, the company exports its products. Arvee Laboratories (India) Ltd. was incorporated in 2012 and is based in Ahmedabad, India.

arveelabs.com

65

Full Time Employees

March 31

Fiscal Year Ends

Recent News: ARVEE.NS

View More

Performance Overview: ARVEE.NS

Trailing total returns as of 1/15/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

ARVEE.NS
11.19%
S&P BSE SENSEX
1.95%

1-Year Return

ARVEE.NS
6.19%
S&P BSE SENSEX
5.73%

3-Year Return

ARVEE.NS
81.04%
S&P BSE SENSEX
25.32%

5-Year Return

ARVEE.NS
478.65%
S&P BSE SENSEX
82.88%

Compare To: ARVEE.NS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ARVEE.NS

View More

Valuation Measures

Annual
As of 1/14/2025
  • Market Cap

    1.72B

  • Enterprise Value

    1.65B

  • Trailing P/E

    75.39

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.63

  • Price/Book (mrq)

    5.54

  • Enterprise Value/Revenue

    4.46

  • Enterprise Value/EBITDA

    33.21

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.52%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    333.51M

  • Net Income Avi to Common (ttm)

    15.06M

  • Diluted EPS (ttm)

    2.08

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    75.4M

  • Total Debt/Equity (mrq)

    3.44%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: ARVEE.NS

View More

Company Insights: ARVEE.NS

Research Reports: ARVEE.NS

View More

People Also Watch